Skip to main content
. 2021 Mar 1;40(9):3755–3763. doi: 10.1007/s10067-021-05660-4

Key Points

• Autoimmune rheumatic diseases (ARD) significantly increased the overall risk of PJP, and so did each individual ARD.

• Use of steroids, mycophenolate, cyclophosphamide, biological agents, methotrexate, and cyclosporine all significantly increased risk of PJP.

• Male, elderly, malignancy, HIV, and interstitial lung disease are also related to increased risk of PJP.

• Underlying ARD, comorbidities, and use of immunosuppressant should all be considered in determining the overall risk of PJP.